Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christel Menet

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|October 26, 2012
Type II kinase inhibitors: an opportunity in cancer for rational designJavier Blanc, Raphaël Geney, Christel Menet
Trends in Pharmacological Sciences|December 3, 2021
Wandering beyond small molecules: peptides as allosteric protein modulatorsMorgane Mannes, Charlotte Martin, Christel Menet, et al.
Molecular Biotechnology|April 28, 2025
pFastBac4x: A Novel Vector for the Simultaneous Expression of Four Proteins-Expression and Purification of a G-Protein Complex as a Case StudyIoanna Ramou, Steven Janvier, Pieter Claes, et al.
Current Opinion in Drug Discovery & Development|August 8, 2006
Expediting drug discovery: recent advances in fast medicinal chemistry--optimization of hits and leadsPaul J Edwards, Brigitte Allart, Martin J I Andrews, et al.
Protein Expression and Purification|January 6, 2025
Expression and purification of an activated orexin receptor 1- G-protein complexIoanna Ramou, Steven Janvier, Sarah Druwé, et al.
Frontiers in Pharmacology|November 7, 2022
Modulation of sleep behavior in zebrafish larvae by pharmacological targeting of the orexin receptorMarie Pardon, Pieter Claes, Sarah Druwé, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2006
Design and synthesis of APTCs (aminopyrrolidinetricarboxylic acids): identification of a new group III metabotropic glutamate receptor selective agonistStephan Schann, Christel Menet, Paul Arvault, et al.
Frontiers in Molecular Biosciences|June 9, 2022
Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHsToon Laeremans, Zara A Sands, Pieter Claes, et al.
Journal of Medicinal Chemistry|January 5, 2021
Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic FibrosisSteven E Van der Plas, Hans Kelgtermans, Oscar Mammoliti, et al.
Journal of Medicinal Chemistry|May 3, 2021
Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary FibrosisOscar Mammoliti, Adeline Palisse, Caroline Joannesse, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Anti-Cancer Agents in Medicinal Chemistry|October 26, 2012
Type II kinase inhibitors: an opportunity in cancer for rational designJavier Blanc, Raphaël Geney, Christel Menet
Trends in Pharmacological Sciences|December 3, 2021
Wandering beyond small molecules: peptides as allosteric protein modulatorsMorgane Mannes, Charlotte Martin, Christel Menet, et al.
Molecular Biotechnology|April 28, 2025
pFastBac4x: A Novel Vector for the Simultaneous Expression of Four Proteins-Expression and Purification of a G-Protein Complex as a Case StudyIoanna Ramou, Steven Janvier, Pieter Claes, et al.
Current Opinion in Drug Discovery & Development|August 8, 2006
Expediting drug discovery: recent advances in fast medicinal chemistry--optimization of hits and leadsPaul J Edwards, Brigitte Allart, Martin J I Andrews, et al.
Protein Expression and Purification|January 6, 2025
Expression and purification of an activated orexin receptor 1- G-protein complexIoanna Ramou, Steven Janvier, Sarah Druwé, et al.
Frontiers in Pharmacology|November 7, 2022
Modulation of sleep behavior in zebrafish larvae by pharmacological targeting of the orexin receptorMarie Pardon, Pieter Claes, Sarah Druwé, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2006
Design and synthesis of APTCs (aminopyrrolidinetricarboxylic acids): identification of a new group III metabotropic glutamate receptor selective agonistStephan Schann, Christel Menet, Paul Arvault, et al.
Frontiers in Molecular Biosciences|June 9, 2022
Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHsToon Laeremans, Zara A Sands, Pieter Claes, et al.
Journal of Medicinal Chemistry|January 5, 2021
Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic FibrosisSteven E Van der Plas, Hans Kelgtermans, Oscar Mammoliti, et al.
Journal of Medicinal Chemistry|May 3, 2021
Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary FibrosisOscar Mammoliti, Adeline Palisse, Caroline Joannesse, et al.
Pageof 2